> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# FDA Exempts Some from Supply Chain Security Act
- URL: https://www.fdaweb.com/fda-exempts-some-from-supply-chain-security-act/
- Published: 2024-10-09T12:00:00.000Z
- Updated: 2026-09-14T14:43:30.000Z
- Author: David McFarland
- Tags: Drugs, #legacy-id-D5157950

FDA has issued an exemption from the enhanced drug distribution security requirements of the Drug Supply Chain Security Act for eligible trading partners. An agency [notice](https://www.fda.gov/drugs/drug-supply-chain-security-act-dscsa/waivers-and-exemptions-beyond-stabilization-period?utm%5Fmedium=email&utm%5Fsource=govdelivery) says the exemption applies to any product transacted by eligible trading partners, trading partners who have successfully completed or made documented efforts to complete data connections with their immediate trading partners but still face challenges exchanging data. The notice says the exemption “is part of the agency’s broader efforts to avoid supply chain disruptions and ensure patients will not face delays in receiving the medicines they need.”

The duration of the exemption, FDA says, varies depending on the eligible trading partners: manufacturers and repackagers, 5/27/2025; wholesale distributors, 8/27/2025; and dispensers with 26 or more full-time employees, 11/27/2025.

The notice says that trading partners that do not qualify for these exemptions and are unable to meet the enhanced drug distribution security requirements may request a waiver, exception, or exemption from those requirements that take effect 11/27.